Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Arestin - Use in Subjects With Peri-Implantitis (With Subgingival Microbiological Evaluation)

This study has been completed.
Information provided by (Responsible Party):
OraPharma Identifier:
First received: January 10, 2012
Last updated: August 25, 2015
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: November 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)